High-density lipoprotein particles, coronary heart disease, and niacin

Journal of Clinical Lipidology

Volumn 4, Issue 5, 2010, Pages 405-410

  Asztalos, Bela F ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

CHD; HDL particles; HDL raising; HDL C; High density lipoprotein; Niacin

Indexed keywords

ABC TRANSPORTER A1; CHOLESTEROL ESTER TRANSFER PROTEIN INHIBITOR; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIVER TRIACYLGLYCEROL LIPASE; NICOTINIC ACID; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; SCAVENGER RECEPTOR BI; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

CARDIOVASCULAR RISK; CHOLESTEROL METABOLISM; CONFERENCE PAPER; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; HEART PROTECTION; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT;

APOLIPOPROTEIN A-I; CARDIOVASCULAR DISEASES; CHOLESTEROL ESTER TRANSFER PROTEINS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPOLIPIDEMIC AGENTS; LIPOPROTEINS, HDL; NIACIN; RISK FACTORS;

EID: 77957871418     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2010.08.012     Document Type: Conference Paper

References (23)

1. W.P. Castelli, K. Anderson, and P.W. Wilson Lipids and risk for coronary heart disease: the Framingham Study Ann Epidemiol 2 1992 23 28
2. D.J. Gordon, and B.M. Rifkind High-density lipoprotein - the clinical implications of recent studies N Engl J Med 321 1989 1311 1316
3. P.W. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
4. J.J. Genest Jr., S.S. Martin-Munley, and J.R. McNamara Familial lipoprotein disorders in patients with premature coronary artery disease Circulation 85 1992 2025 2033
5. S.J. Nicholls, E.M. Tuzcu, and I. Sipahi Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis JAMA 297 2007 499 508
6. B.G. Brown, K.H. Stukovsky, and X.Q. Zhao Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized lipid trials Curr Opin Lipidol 17 2006 631 636
7. T. Vaisar, S. Pennathur, and P.S. Green Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL J Clin Invest 117 2007 746 756
8. B.F. Asztalos, C.H. Sloop, L. Wong, and P.S. Roheim Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apo A-I-containing subpopulations Biochim Biophys Acta 1169 1993 291 300
9. R.D. Santos, E.J. Schaefer, and B.F. Asztalos Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency J Lipid Res 49 2008 349 357
10. B.F. Asztalos, M.E. Brousseau, J.R. McNamara, K.V. Horvath, P.S. Roheim, and E.J. Schaefer Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease Atherosclerosis 156 2001 217 225
11. B.F. Asztalos, E.J. Schaefer, and K.V. Horvath Role of LCAT in HDL remodeling: investigation of LCAT deficiency states J Lipid Res 48 2007 592 599
12. B.F. Asztalos, K.V. Horvath, and K. Kajinami Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency J Lipid Res 45 2004 448 455
13. B.F. Asztalos, M. de la Llera-Moya, G.E. Dallal, K.V. Horvath, E.J. Schaefer, and G.H. Rothblat Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux J Lipid Res 46 2005 2246 2253
14. B.F. Asztalos, L.A. Cupples, and S. Demissie High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study Arterioscler Thromb Vasc Biol 24 2004 2181 2187
15. B.F. Asztalos, D. Collins, and L.A. Cupples Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial Arterioscler Thromb Vasc Biol 25 2005 2185 2191
16. B.F. Asztalos, D. Collins, K.V. Horvath, H.E. Bloomfield, S.J. Robins, and E.J. Schaefer Relation of gemfibrozil treatment and high-density lipoprotein subpopulation profile with cardiovascular events in the Veterans Affairs High-Density Lipoprotein Intervention Trial Metabolism 57 2008 77 83
17. B.F. Asztalos, K.V. Horvath, J.R. McNamara, P.S. Roheim, J.J. Rubinstein, and E.J. Schaefer Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients Atherosclerosis 164 2002 361 369
18. B.F. Asztalos, F. Le Maulf, and G.E. Dallal Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins Am J Cardiol 99 2007 681 685
19. R. Altschul, A. Hoffer, and J.D. Stephen Influence of nicotinic acid on serum cholesterol in man Arch Biochem 54 1955 558 569
20. B.G. Brown, X.Q. Zhao, and A. Chait Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease N Engl J Med 345 2001 1583 1592
21. B.F. Asztalos, M. Batista, and K.V. Horvath Change in alpha1 HDL concentration predicts progression in coronary artery stenosis Arterioscler Thromb Vasc Biol 23 2003 847 852
22. S.E. Nissen, T. Tsunoda, and E.M. Tuzcu Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial JAMA 290 2003 2292 2300
23. A.J. Taylor, T.C. Villines, and E.J. Stanek Extended-release niacin or ezetimibe and carotid intima-media thickness N Engl J Med 361 2009 2113 2122